{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T21:19:39Z","timestamp":1792876779253,"version":"4.5.0"},"reference-count":108,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001824","name":"Czech Science Foundation","doi-asserted-by":"publisher","award":["22- 05318S"],"award-info":[{"award-number":["22- 05318S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001824","name":"Czech Science Foundation","doi-asserted-by":"publisher","award":["22-12859S"],"award-info":[{"award-number":["22-12859S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.tips.2022.04.008","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T11:13:42Z","timestamp":1653477222000},"page":"593-606","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Countermeasures in organophosphorus intoxication: pitfalls and prospects"],"prefix":"10.1016","volume":"43","author":[{"given":"Lukas","family":"Gorecki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Soukup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6977-7596","authenticated-orcid":false,"given":"Jan","family":"Korabecny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2022.04.008_bb0005","series-title":"Dreams and Shadows: The Future of the Middle East","author":"Wright","year":"2009"},{"key":"10.1016\/j.tips.2022.04.008_bb0010","series-title":"Natural and Selected Synthetic Toxins","first-page":"304","article-title":"Overview of sarin terrorist attacks in Japan","volume":"745","author":"Tu","year":"1999"},{"key":"10.1016\/j.tips.2022.04.008_bb0015","doi-asserted-by":"crossref","first-page":"644","DOI":"10.7326\/M13-2799","article-title":"Lessons learned from the Syrian sarin attack: evaluation of a clinical syndrome through social media","volume":"160","author":"Rosman","year":"2014","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.tips.2022.04.008_bb0020","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/24734306.2017.1373503","article-title":"Toxic chemical weapons of assassination and warfare: nerve agents VX and sarin","volume":"1","author":"Chai","year":"2017","journal-title":"Toxicol. Commun."},{"key":"10.1016\/j.tips.2022.04.008_bb0025","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12889-020-8339-z","article-title":"Suicide by pesticide poisoning in India: a review of pesticide regulations and their impact on suicide trends","volume":"20","author":"Bonvoisin","year":"2020","journal-title":"BMC Public Health"},{"key":"10.1016\/j.tips.2022.04.008_bb0030","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1146\/annurev-pharmtox-010818-021842","article-title":"Novel clinical toxicology and pharmacology of organophosphorus insecticide self-poisoning","volume":"59","author":"Eddleston","year":"2019","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.tips.2022.04.008_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00139709-200625010-00001","article-title":"Organophosphate-induced intermediate syndrome: aetiology and relationships with myopathy","volume":"25","author":"Karalliedde","year":"2006","journal-title":"Toxicol. Rev."},{"key":"10.1016\/j.tips.2022.04.008_bb0040","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cbi.2012.07.002","article-title":"Mechanisms for consideration for intervention in the development of organophosphorus-induced delayed neuropathy","volume":"199","author":"Emerick","year":"2012","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tips.2022.04.008_bb0045","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1056\/NEJMra1705224","article-title":"Toxidrome recognition in chemical-weapons attacks","volume":"378","author":"Ciottone","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tips.2022.04.008_bb0050","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s00204-020-02797-0","article-title":"Organophosphorus compounds and oximes: a critical review","volume":"94","author":"Worek","year":"2020","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tips.2022.04.008_bb0055","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.bja.2019.04.061","article-title":"Organophosphorus nerve agent poisoning: managing the poisoned patient","volume":"123","author":"Hulse","year":"2019","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.tips.2022.04.008_bb0060","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1021\/acschemneuro.8b00615","article-title":"DARK classics in chemical neuroscience: atropine, scopolamine, and other anticholinergic deliriant hallucinogens","volume":"10","author":"Lakstygal","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.tips.2022.04.008_bb0065","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s13181-013-0324-9","article-title":"Comparison of current recommended regimens of atropinization in organophosphate poisoning","volume":"10","author":"Connors","year":"2014","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.tips.2022.04.008_bb0070","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/00003246-199009000-00010","article-title":"Organophosphate poisoning: grading the severity and comparing treatment between atropine and glycopyrrolate","volume":"18","author":"Bardin","year":"1990","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.tips.2022.04.008_bb0075","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1197\/aemj.10.3.290","article-title":"A role for ipratropium in chemical terrorism preparedness","volume":"10","author":"Perrone","year":"2003","journal-title":"Acad. Emerg. Med."},{"key":"10.1016\/j.tips.2022.04.008_bb0080","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF03012025","article-title":"The use of glycopyrrolate in a case of intermediate syndrome following acute organophosphate poisoning","volume":"45","author":"Choi","year":"1998","journal-title":"Can. J. Anaesth."},{"key":"10.1016\/j.tips.2022.04.008_bb0085","article-title":"Anticonvulsant effectiveness of scopolamine against soman-induced seizures in African green monkeys","author":"McDonough","year":"2021","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.tips.2022.04.008_bb0090","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.tox.2014.09.005","article-title":"Caramiphen edisylate: an optimal antidote against organophosphate poisoning","volume":"325","author":"Raveh","year":"2014","journal-title":"Toxicology"},{"key":"10.1016\/j.tips.2022.04.008_bb0095","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.toxlet.2017.10.009","article-title":"In vitro pharmacological characterization of the bispyridinium non-oxime compound MB327 and its 2- and 3-regioisomers","volume":"293","author":"Niessen","year":"2018","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.tips.2022.04.008_bb0100","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.toxlet.2017.11.006","article-title":"Efficacy of the antinicotinic compound MB327 against soman poisoning \u2013 importance of experimental end point","volume":"293","author":"Price","year":"2018","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.tips.2022.04.008_bb0105","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.toxlet.2017.12.005","article-title":"Counteracting desensitization of human \u03b17-nicotinic acetylcholine receptors with bispyridinium compounds as an approach against organophosphorus poisoning","volume":"293","author":"Scheffel","year":"2018","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.tips.2022.04.008_bb0110","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1080\/15563650.2019.1643467","article-title":"A pilot clinical study of the neuromuscular blocker rocuronium to reduce the duration of ventilation after organophosphorus insecticide poisoning","volume":"58","author":"Dhanarisi","year":"2020","journal-title":"Clin. Toxicol. (Phila.)"},{"key":"10.1016\/j.tips.2022.04.008_bb0115","series-title":"Goodman and Gilman\u2019s The Pharmacological Basis of Therapeutics","first-page":"163","article-title":"Anticholinesterase agents","author":"Taylor","year":"2017"},{"key":"10.1016\/j.tips.2022.04.008_bb0120","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/014107680509800307","article-title":"Nicotinic antagonists in the treatment of nerve agent intoxication","volume":"98","author":"Sheridan","year":"2005","journal-title":"J. R. Soc. Med."},{"key":"10.1016\/j.tips.2022.04.008_bb0125","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/nyas.13028","article-title":"Long-term neuropathological and behavioral impairments after exposure to nerve agents","volume":"1374","author":"Aroniadou-Anderjaska","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.tips.2022.04.008_bb0130","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neuro.2014.04.006","article-title":"Development of status epilepticus, sustained calcium elevations and neuronal injury in a rat survival model of lethal paraoxon intoxication","volume":"44","author":"Deshpande","year":"2014","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.tips.2022.04.008_bb0135","doi-asserted-by":"crossref","first-page":"11032","DOI":"10.1523\/JNEUROSCI.1848-10.2010","article-title":"The muscarinic long-term enhancement of NMDA and AMPA receptor-mediated transmission at Schaffer collateral synapses develop through different intracellular mechanisms","volume":"30","author":"Fern\u00e1ndez de Sevilla","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2022.04.008_bb0140","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1080\/10408444.2020.1787330","article-title":"A national toxicology program systematic review of the evidence for long-term effects after acute exposure to sarin nerve agent","volume":"50","author":"Jett","year":"2020","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.tips.2022.04.008_bb0145","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2017.04.019","article-title":"Simultaneous triple therapy for the treatment of status epilepticus","volume":"104","author":"Niquet","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tips.2022.04.008_bb0150","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2165\/00139709-200322020-00002","article-title":"Diazepam in the treatment of organophosphorus ester pesticide poisoning","volume":"22","author":"Marrs","year":"2003","journal-title":"Toxicol. Rev."},{"key":"10.1016\/j.tips.2022.04.008_bb0155","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/epi.12989","article-title":"Midazolam as an anticonvulsant antidote for organophosphate intoxication\u2014a pharmacotherapeutic appraisal","volume":"56","author":"Reddy","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.tips.2022.04.008_bb0160","series-title":"Medical Management of CBRN Casualties","author":"NATO","year":"2018"},{"key":"10.1016\/j.tips.2022.04.008_bb0165","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(20)32644-1","article-title":"Novichok nerve agent poisoning","volume":"397","author":"Steindl","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.tips.2022.04.008_bb0170","series-title":"FDA Approval of Anti-seizure Drug Provides a New Tool for Protecting Americans During a Chemical Attack","author":"Laney","year":"2018"},{"key":"10.1016\/j.tips.2022.04.008_bb0175","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.neuro.2014.08.008","article-title":"Chronic behavioral and cognitive deficits in a rat survival model of paraoxon toxicity","volume":"44","author":"Deshpande","year":"2014","journal-title":"NeuroToxicology"},{"key":"10.1016\/j.tips.2022.04.008_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.02.017","article-title":"Targeting the glutamatergic system to counteract organophosphate poisoning: a novel therapeutic strategy","volume":"133","author":"Aroniadou-Anderjaska","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tips.2022.04.008_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108298","article-title":"Acetylcholinesterase inhibitors (nerve agents) as weapons of mass destruction: history, mechanisms of action, and medical countermeasures","volume":"181","author":"Aroniadou-Anderjaska","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.tips.2022.04.008_bb0190","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/nyas.14331","article-title":"Electroencephalographic analysis in soman-exposed 21-day-old rats and the effects of midazolam or LY293558 with caramiphen","volume":"1479","author":"De Araujo Furtado","year":"2020","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.tips.2022.04.008_bb0195","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/0006-3002(55)90040-8","article-title":"A powerful reactivator of alkylphosphate-inhibited acetylcholinesterase","volume":"18","author":"Wilson","year":"1955","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tips.2022.04.008_bb0200","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/1821498a0","article-title":"New potent reactivators of acetocholinesterase inhibited by tetraethyl pyrophosphate","volume":"182","author":"Hobbiger","year":"1958","journal-title":"Nature"},{"key":"10.1016\/j.tips.2022.04.008_bb0205","first-page":"1","article-title":"Quaternary hydroxyiminomethylpyridinium salts. The dischloride of bis-(4-hydroxyiminomethyl-1-pyridinium-methyl)-ether (LUEH6), a new reactivator of acetylcholinesterase inhibited by organic phosphoric acid esters","volume":"14","author":"Luettringhaus","year":"1964","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.tips.2022.04.008_bb0210","first-page":"603","article-title":"Reactivation of phosphorylated acetylcholine esterase with oximes: contribution to the study of the reaction course","volume":"19","author":"Hagedorn","year":"1969","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.tips.2022.04.008_bb0215","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/jps.2600600823","article-title":"Intramuscular and intravenous administration of small doses of 2-pyridinium aldoxime methochloride to man","volume":"60","author":"Sidell","year":"1971","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.tips.2022.04.008_bb0220","article-title":"Oximes for acute organophosphate pesticide poisoning","volume":"2005","author":"Buckley","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.tips.2022.04.008_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000104","article-title":"Pralidoxime in acute organophosphorus insecticide poisoning--a randomised controlled trial","volume":"6","author":"Eddleston","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.tips.2022.04.008_bb0230","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0140-6736(07)61202-1","article-title":"Management of acute organophosphorus pesticide poisoning","volume":"371","author":"Eddleston","year":"2008","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.tips.2022.04.008_bb0235","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1080\/15563650903206828","article-title":"Obidoxime in acute organophosphate poisoning: 1 \u2013 clinical effectiveness","volume":"47","author":"Eyer","year":"2009","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.tips.2022.04.008_bb0240","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1177\/096032719701600809","article-title":"Cholinesterase status, pharmacokinetics and laboratory findings during obidoxime therapy in organophosphate poisoned patients","volume":"16","author":"Thiermann","year":"1997","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.tips.2022.04.008_bb0245","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/sj.clpt.6100151","article-title":"Novel nerve-agent antidote design based on crystallographic and mass spectrometric analyses of tabun-conjugated acetylcholinesterase in complex with antidotes","volume":"82","author":"Ekstr\u00f6m","year":"2007","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.tips.2022.04.008_bb0250","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.1074\/jbc.270.11.6370","article-title":"Amino acid residues controlling reactivation of organophosphonyl conjugates of acetylcholinesterase by mono- and bisquaternary oximes","volume":"270","author":"Ashani","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2022.04.008_bb0255","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.tips.2020.04.008","article-title":"A perspective on multi-target drugs for Alzheimer\u2019s disease","volume":"41","author":"Benek","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tips.2022.04.008_bb0260","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.bcp.2004.07.038","article-title":"Kinetic analysis of interactions between human acetylcholinesterase, structurally different organophosphorus compounds and oximes","volume":"68","author":"Worek","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tips.2022.04.008_bb0265","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1007\/s00204-016-1827-3","article-title":"SAR study to find optimal cholinesterase reactivator against organophosphorous nerve agents and pesticides","volume":"90","author":"Gorecki","year":"2016","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tips.2022.04.008_bb0270","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.taap.2006.10.001","article-title":"Recent advances in evaluation of oxime efficacy in nerve agent poisoning by in vitro analysis","volume":"219","author":"Worek","year":"2007","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tips.2022.04.008_bb0275","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/BF01981499","article-title":"HL\u00f6 7 dimethanesulfonate, a potent bispyridinium-dioxime against anticholinesterases","volume":"66","author":"Eyer","year":"1992","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tips.2022.04.008_bb0280","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.taap.2014.10.009","article-title":"A comprehensive evaluation of the efficacy of leading oxime therapies in guinea pigs exposed to organophosphorus chemical warfare agents or pesticides","volume":"281","author":"Wilhelm","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tips.2022.04.008_bb0285","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.neuro.2018.07.014","article-title":"Evaluating the broad-spectrum efficacy of the acetylcholinesterase oximes reactivators MMB4 DMS, HL\u00f6-7 DMS, and 2-PAM Cl against phorate oxon, sarin, and VX in the Hartley guinea pig","volume":"68","author":"Wilhelm","year":"2018","journal-title":"NeuroToxicology"},{"key":"10.1016\/j.tips.2022.04.008_bb0290","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2174\/138527207779316417","article-title":"Progress in synthesis of new acetylcholinesterase reactivators during the period 1990-2004","volume":"11","author":"Musilek","year":"2007","journal-title":"Curr. Org. Chem."},{"key":"10.1016\/j.tips.2022.04.008_bb0295","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/med.20192","article-title":"Design, evaluation and structure-activity relationship studies of the AChE reactivators against organophosphorus pesticides","volume":"31","author":"Musilek","year":"2011","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.tips.2022.04.008_bb0300","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00204-018-2377-7","article-title":"Oxime K203: a drug candidate for the treatment of tabun intoxication","volume":"93","author":"Gorecki","year":"2019","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tips.2022.04.008_bb0305","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/cmdc.200900455","article-title":"Monooxime-monocarbamoyl bispyridinium xylene-linked reactivators of acetylcholinesterase-synthesis, in vitro and toxicity evaluation, and docking studies","volume":"5","author":"Musilek","year":"2010","journal-title":"ChemMedChem"},{"key":"10.1016\/j.tips.2022.04.008_bb0310","doi-asserted-by":"crossref","first-page":"10753","DOI":"10.1021\/acs.jmedchem.8b01398","article-title":"Pyridinium oximes with ortho-positioned chlorine moiety exhibit improved physicochemical properties and efficient reactivation of human acetylcholinesterase inhibited by several nerve agents","volume":"61","author":"Zorbaz","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2022.04.008_bb0315","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.xphs.2021.01.031","article-title":"Determination of K869, a novel oxime reactivator of acetylcholinesterase, in rat body fluids and tissues by liquid-chromatography methods: pharmacokinetic study","volume":"110","author":"Vanova","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.tips.2022.04.008_bb0320","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2174\/092986708783955563","article-title":"Entry of oximes into the brain: a review","volume":"15","author":"Lorke","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.tips.2022.04.008_bb0325","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1007\/s00204-020-02811-5","article-title":"Targeting organophosphorus compounds poisoning by novel quinuclidine-3 oximes: development of butyrylcholinesterase-based bioscavengers","volume":"94","author":"Zandona","year":"2020","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tips.2022.04.008_bb0330","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1021\/jm401650z","article-title":"Imidazole aldoximes effective in assisting butyrylcholinesterase catalysis of organophosphate detoxification","volume":"57","author":"Sit","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2022.04.008_bb0335","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1080\/14756366.2019.1710501","article-title":"Synthesis, in vitro screening and molecular docking of isoquinolinium-5-carbaldoximes as acetylcholinesterase and butyrylcholinesterase reactivators","volume":"35","author":"Malinak","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.tips.2022.04.008_bb0340","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/nyas.13053","article-title":"Novel brain-penetrating oximes for reactivation of cholinesterase inhibited by sarin and VX surrogates","volume":"1374","author":"Chambers","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.tips.2022.04.008_bb0345","doi-asserted-by":"crossref","first-page":"9376","DOI":"10.1021\/acs.jmedchem.7b01083","article-title":"Application of the Ugi multicomponent reaction in the synthesis of reactivators of nerve agent inhibited acetylcholinesterase","volume":"60","author":"de Koning","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2022.04.008_bb0350","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s00204-021-02981-w","article-title":"Development of versatile and potent monoquaternary reactivators of acetylcholinesterase","volume":"95","author":"Gorecki","year":"2021","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tips.2022.04.008_bb0355","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.pharmthera.2013.04.009","article-title":"The value of novel oximes for treatment of poisoning by organophosphorus compounds","volume":"139","author":"Worek","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.tips.2022.04.008_bb0360","first-page":"5337","article-title":"Resurrection and reactivation of acetylcholinesterase and butyrylcholinesterase","volume":"25","author":"Franjesevic","year":"2019","journal-title":"Chem. Weinh. Bergstr. Ger."},{"key":"10.1016\/j.tips.2022.04.008_bb0365","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cbi.2010.02.015","article-title":"Pro-2-PAM therapy for central and peripheral cholinesterases","volume":"187","author":"DeMar","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tips.2022.04.008_bb0370","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3109\/15376516.2010.529190","article-title":"The oxime pro-2-PAM provides minimal protection against the CNS effects of the nerve agents sarin, cyclosarin, and VX in guinea pigs","volume":"21","author":"Shih","year":"2011","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.tips.2022.04.008_bb0375","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12031-009-9259-7","article-title":"Treatment with tertiary oximes prevents seizures and improves survival following sarin intoxication","volume":"40","author":"Shih","year":"2010","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.tips.2022.04.008_bb0380","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1021\/acschemneuro.0c00032","article-title":"Pharmacokinetic evaluation of brain penetrating morpholine-3-hydroxy-2-pyridine oxime as an antidote for nerve agent poisoning","volume":"11","author":"Zorbaz","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.tips.2022.04.008_bb0385","doi-asserted-by":"crossref","first-page":"11798","DOI":"10.1074\/jbc.M111.333732","article-title":"Refinement of structural leads for centrally acting oxime reactivators of phosphylated cholinesterases","volume":"287","author":"Radi\u0107","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2022.04.008_bb0390","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1074\/jbc.RA119.012400","article-title":"Rational design, synthesis, and evaluation of uncharged, \u201csmart\u201d bis-oxime antidotes of organophosphate-inhibited human acetylcholinesterase","volume":"295","author":"Gorecki","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2022.04.008_bb0395","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cbi.2017.07.003","article-title":"Post-exposure treatment with the oxime RS194B rapidly reverses early and advanced symptoms in macaques exposed to sarin vapor","volume":"274","author":"Rosenberg","year":"2017","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tips.2022.04.008_bb0400","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cbi.2017.09.016","article-title":"The biodistribution and pharmacokinetics of the oxime acetylcholinesterase reactivator RS194B in guinea pigs","volume":"277","author":"Malfatti","year":"2017","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tips.2022.04.008_bb0405","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cbi.2016.04.002","article-title":"Probing the activity of a non-oxime reactivator for acetylcholinesterase inhibited by organophosphorus nerve agents","volume":"259","author":"Cadieux","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tips.2022.04.008_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109139","article-title":"Synthesis and in vitro evaluation of novel non-oximes for the reactivation of nerve agent inhibited human acetylcholinesterase","volume":"326","author":"de Koning","year":"2020","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tips.2022.04.008_bb0415","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.toxlet.2011.05.231","article-title":"Increasing oxime efficacy by blood\u2013brain barrier modulation","volume":"206","author":"Joosen","year":"2011","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.tips.2022.04.008_bb0420","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.tox.2019.05.006","article-title":"Current approaches to enhancing oxime reactivator delivery into the brain","volume":"423","author":"Kobrlova","year":"2019","journal-title":"Toxicology"},{"key":"10.1016\/j.tips.2022.04.008_bb0425","doi-asserted-by":"crossref","first-page":"16922","DOI":"10.1021\/acsami.7b04163","article-title":"Nanoparticle-delivered 2-PAM for rat brain protection against paraoxon central toxicity","volume":"9","author":"Pashirova","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.tips.2022.04.008_bb0430","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jconrel.2018.10.010","article-title":"Combination delivery of two oxime-loaded lipid nanoparticles: time-dependent additive action for prolonged rat brain protection","volume":"290","author":"Pashirova","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.tips.2022.04.008_bb0435","doi-asserted-by":"crossref","first-page":"9537","DOI":"10.1039\/C5NR06658A","article-title":"Rapid-releasing of HI-6 via brain-targeted mesoporous silica nanoparticles for nerve agent detoxification","volume":"8","author":"Yang","year":"2016","journal-title":"Nanoscale"},{"key":"10.1016\/j.tips.2022.04.008_bb0440","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jconrel.2020.10.039","article-title":"Brain-targeted delivery of obidoxime, using aptamer-modified liposomes, for detoxification of organophosphorus compounds","volume":"329","author":"Zhang","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.tips.2022.04.008_bb0445","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.neuro.2015.12.020","article-title":"Intranasal delivery of obidoxime to the brain prevents mortality and CNS damage from organophosphate poisoning","volume":"53","author":"Krishnan","year":"2016","journal-title":"NeuroToxicology"},{"key":"10.1016\/j.tips.2022.04.008_bb0450","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.colsurfb.2018.07.049","article-title":"Mixed cationic liposomes for brain delivery of drugs by the intranasal route: the acetylcholinesterase reactivator 2-PAM as encapsulated drug model","volume":"171","author":"Pashirova","year":"2018","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.tips.2022.04.008_bb0455","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ejpb.2018.05.009","article-title":"Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics","volume":"128","author":"Bourganis","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.tips.2022.04.008_bb0460","doi-asserted-by":"crossref","first-page":"7032","DOI":"10.1021\/acs.jmedchem.8b01122","article-title":"Resurrection biology: aged acetylcholinesterase brought back to life","volume":"61","author":"Quinn","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2022.04.008_bb0465","doi-asserted-by":"crossref","first-page":"7034","DOI":"10.1021\/acs.jmedchem.7b01620","article-title":"Demonstration of in vitro resurrection of aged acetylcholinesterase after exposure to organophosphorus chemical nerve agents","volume":"61","author":"Zhuang","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2022.04.008_bb0470","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1007\/s00204-020-02741-2","article-title":"A case report of cholinesterase inhibitor poisoning: cholinesterase activities and analytical methods for diagnosis and clinical decision making","volume":"94","author":"Amend","year":"2020","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tips.2022.04.008_bb0475","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1042\/BJ20121612","article-title":"Catalytic detoxification of nerve agent and pesticide organophosphates by butyrylcholinesterase assisted with non-pyridinium oximes","volume":"450","author":"Radi\u0107","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.tips.2022.04.008_bb0480","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1007\/s00204-016-1776-x","article-title":"Pseudocatalytic scavenging of the nerve agent VX with human blood components and the oximes obidoxime and HI-6","volume":"91","author":"Wille","year":"2017","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tips.2022.04.008_bb0485","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cbi.2018.07.006","article-title":"Catalytic bioscavengers as countermeasures against organophosphate nerve agents","volume":"292","author":"Goldsmith","year":"2018","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tips.2022.04.008_bb0490","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.cbi.2012.08.018","article-title":"Human plasma-derived BuChE as a stoichiometric bioscavenger for treatment of nerve agent poisoning","volume":"203","author":"Mumford","year":"2013","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tips.2022.04.008_bb0495","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.toxlet.2017.11.029","article-title":"Bioscavenger is effective as a delayed therapeutic intervention following percutaneous VX poisoning in the guinea-pig","volume":"293","author":"Mann","year":"2018","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.tips.2022.04.008_bb0500","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00204-021-03199-6","article-title":"Post-VX exposure treatment of rats with engineered phosphotriesterases","volume":"96","author":"Stigler","year":"2022","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tips.2022.04.008_bb0505","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000007237","article-title":"Clinical emergency treatment of 68 critical patients with severe organophosphorus poisoning and prognosis analysis after rescue","volume":"96","author":"Dong","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.tips.2022.04.008_bb0510","first-page":"677","article-title":"Dual opposite actions of sodium bicarbonate in treatment of acute organophosphate poisoning","volume":"18","author":"Shetab-Boushehri","year":"2019","journal-title":"EXCLI J."},{"key":"10.1016\/j.tips.2022.04.008_bb0515","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1139\/cjpp-2014-0113","article-title":"Potential pharmacological strategies for the improved treatment of organophosphate-induced neurotoxicity","volume":"92","author":"Kaur","year":"2014","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.tips.2022.04.008_bb0520","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40360-018-0227-0","article-title":"The benefit of combinations of oximes for the ability of antidotal treatment to counteract sarin-induced brain damage in rats","volume":"19","author":"Caisberger","year":"2018","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10.1016\/j.tips.2022.04.008_bb0525","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.ajem.2009.01.035","article-title":"Carbamate poisoning: treatment recommendations in the setting of a mass casualties event","volume":"27","author":"Rosman","year":"2009","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.tips.2022.04.008_bb0530","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/15569543.2014.994131","article-title":"Gulf war syndrome \u2013 a syndrome or not?","volume":"34","author":"Patocka","year":"2015","journal-title":"Toxin Rev."},{"key":"10.1016\/j.tips.2022.04.008_bb0535","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1073\/pnas.0711986105","article-title":"Acetylcholinesterase inhibitors and Gulf War illnesses","volume":"105","author":"Golomb","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2022.04.008_bb0540","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.emc.2014.09.010","article-title":"Organophosphate and carbamate poisoning","volume":"33","author":"King","year":"2015","journal-title":"Emerg. Med. Clin. North Am."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614722000888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614722000888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:51:27Z","timestamp":1777495887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614722000888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":108,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0165614722000888"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2022.04.008","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Countermeasures in organophosphorus intoxication: pitfalls and prospects","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2022.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}